+91-22-48913909
Table of Contents
Best Equity Mutual Funds of 2024
Equity Funds are the ones whose accumulated fund money is invested in equity and equity-related instruments of various companies. The equity funds are considered as a long-term investment option for people having a moderate and high-risk appetite. The various categories of equity funds include Large cap funds, mid cap funds, Small cap funds, ELSS, and so on. In the year 2024, there was an upsurge witnessed in the equity markets due to which most of the equity fund categories have performed well. The performance of these funds depends on a lot of macro and microeconomic parameters such as Industry performance, company performance, the earning and profits of the companies, its future potentials, and so on. The top and Best equity funds for the year 2024 are as follows.
Talk to our investment specialist
Top 10 Equity Mutual Funds of 2024 Based on Performance
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) Motilal Oswal Midcap 30 Fund Growth ₹99.4291
↑ 0.40 ₹26,028 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹47.6892
↑ 0.88 ₹874 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹50.6566
↑ 0.91 ₹3,817 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹60.1363
↑ 0.13 ₹12,267 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹166.99
↑ 0.50 ₹5,779 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹272.199
↓ -0.51 ₹1,042 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹418.188
↑ 2.40 ₹3,611 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹29.5738
↓ -0.03 ₹1,184 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹29.2733
↑ 0.19 ₹494 40 33.4 2.4 64.7 19 L&T Midcap Fund Growth ₹370.562
↑ 2.35 ₹10,362 39.7 40 1.1 30.4 19 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 16 May 25
Top & Best Equity Mutual Funds of 2024
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Midcap 30 Fund is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Multicap 35 Fund is a Equity - Multi Cap fund was launched on 28 Apr 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Invesco India Mid Cap Fund is a Equity - Mid Cap fund was launched on 19 Apr 07. It is a fund with Moderately High risk and has given a Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on To generate capital appreciation by investing primarily in midcap stocks. The scheme will invest primarily in companies whose market capitalization falls between the highest and the lowest constituent of the Nifty Free Float Midcap 100. L&T Midcap Fund is a Equity - Mid Cap fund was launched on 9 Aug 04. It is a fund with High risk and has given a Below is the key information for L&T Midcap Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
CAGR/Annualized return of 22.7% since its launch. Ranked 27 in Mid Cap category. Return for 2024 was 57.1% , 2023 was 41.7% and 2022 was 10.7% . Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (16 May 25) ₹99.4291 ↑ 0.40 (0.41 %) Net Assets (Cr) ₹26,028 on 31 Mar 25 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.66 Sharpe Ratio 0.47 Information Ratio 0.63 Alpha Ratio 8.9 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹15,779 30 Apr 22 ₹22,526 30 Apr 23 ₹24,941 30 Apr 24 ₹40,218 30 Apr 25 ₹45,886 Returns for Motilal Oswal Midcap 30 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 10.5% 3 Month 8% 6 Month -3.2% 1 Year 19.8% 3 Year 32.4% 5 Year 38.2% 10 Year 15 Year Since launch 22.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 57.1% 2023 41.7% 2022 10.7% 2021 55.8% 2020 9.3% 2019 9.7% 2018 -12.7% 2017 30.8% 2016 5.2% 2015 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.58 Yr. Niket Shah 1 Jul 20 4.83 Yr. Rakesh Shetty 22 Nov 22 2.44 Yr. Sunil Sawant 1 Jul 24 0.83 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Technology 29.99% Consumer Cyclical 16.64% Industrials 14.58% Health Care 4.76% Communication Services 3.95% Real Estate 3.03% Basic Materials 2.07% Utility 0.35% Financial Services 0.09% Asset Allocation
Asset Class Value Cash 32.1% Equity 67.9% Top Securities Holdings / Portfolio
Name Holding Value Quantity Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT10% ₹2,794 Cr 5,250,000
↑ 750,200 Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE9% ₹2,630 Cr 3,600,000
↑ 350,000 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL8% ₹2,246 Cr 43,490,250
↑ 3,495,625 Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB5% ₹1,380 Cr 2,500,000
↑ 275,000 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Mar 23 | DIXON4% ₹1,210 Cr 735,200 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | 5002514% ₹1,105 Cr 2,135,744 Bharti Hexacom Ltd (Communication Services)
Equity, Since 31 Oct 24 | BHARTIHEXA4% ₹1,098 Cr 6,500,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 24 | MAXHEALTH4% ₹1,095 Cr 9,969,361 One97 Communications Ltd (Technology)
Equity, Since 30 Sep 24 | 5433964% ₹1,071 Cr 12,388,500 KEI Industries Ltd (Industrials)
Equity, Since 30 Nov 24 | KEI3% ₹827 Cr 2,700,000
↑ 200,000 2. LIC MF Infrastructure Fund
CAGR/Annualized return of 9.4% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (16 May 25) ₹47.6892 ↑ 0.88 (1.89 %) Net Assets (Cr) ₹874 on 31 Mar 25 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 0.41 Information Ratio 0.35 Alpha Ratio 15.98 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹14,908 30 Apr 22 ₹19,688 30 Apr 23 ₹21,272 30 Apr 24 ₹36,718 30 Apr 25 ₹38,183 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 8.8% 3 Month 14% 6 Month -3.2% 1 Year 9% 3 Year 31.4% 5 Year 34% 10 Year 15 Year Since launch 9.4% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.62 Yr. Mahesh Bendre 1 Jul 24 0.83 Yr. Data below for LIC MF Infrastructure Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 57.02% Basic Materials 9.14% Consumer Cyclical 8.07% Utility 7.19% Financial Services 6.17% Real Estate 3.11% Technology 2.31% Communication Services 2.26% Health Care 0.51% Energy 0.44% Asset Allocation
Asset Class Value Cash 3.8% Equity 96.2% Top Securities Holdings / Portfolio
Name Holding Value Quantity Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP4% ₹34 Cr 408,127 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006553% ₹30 Cr 94,287 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004003% ₹28 Cr 724,927 Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | 5001033% ₹24 Cr 1,062,199
↑ 79,197 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹24 Cr 571,332 Hitachi Energy India Ltd Ordinary Shares (Industrials)
Equity, Since 31 Jul 22 | POWERINDIA3% ₹23 Cr 15,928
↑ 2,851 Afcons Infrastructure Ltd (Industrials)
Equity, Since 31 Oct 24 | AFCONS3% ₹22 Cr 537,216
↑ 46,853 Hindustan Aeronautics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Oct 23 | HAL2% ₹22 Cr 49,106
↑ 3,972 TD Power Systems Ltd (Industrials)
Equity, Since 30 Apr 23 | TDPOWERSYS2% ₹21 Cr 476,469 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222752% ₹20 Cr 126,914 3. Motilal Oswal Long Term Equity Fund
CAGR/Annualized return of 16.8% since its launch. Return for 2024 was 47.7% , 2023 was 37% and 2022 was 1.8% . Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (16 May 25) ₹50.6566 ↑ 0.91 (1.83 %) Net Assets (Cr) ₹3,817 on 31 Mar 25 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 0.74 Sharpe Ratio 0.26 Information Ratio 0.83 Alpha Ratio 5.9 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹14,799 30 Apr 22 ₹16,837 30 Apr 23 ₹18,446 30 Apr 24 ₹29,496 30 Apr 25 ₹31,121 Returns for Motilal Oswal Long Term Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 10.2% 3 Month 13.8% 6 Month -1.3% 1 Year 13.4% 3 Year 29.3% 5 Year 28.8% 10 Year 15 Year Since launch 16.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.7% 2023 37% 2022 1.8% 2021 32.1% 2020 8.8% 2019 13.2% 2018 -8.7% 2017 44% 2016 12.5% 2015 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Ajay Khandelwal 11 Dec 23 1.39 Yr. Rakesh Shetty 22 Nov 22 2.44 Yr. Atul Mehra 1 Oct 24 0.58 Yr. Data below for Motilal Oswal Long Term Equity Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 34.02% Consumer Cyclical 21.13% Financial Services 17.41% Technology 9.22% Real Estate 7.02% Basic Materials 6.25% Health Care 2.8% Asset Allocation
Asset Class Value Cash 2.14% Equity 97.86% Top Securities Holdings / Portfolio
Name Holding Value Quantity Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 5433206% ₹231 Cr 9,923,692 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Aug 22 | 5002516% ₹220 Cr 425,260 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES4% ₹171 Cr 297,751 Gujarat Fluorochemicals Ltd Ordinary Shares (Basic Materials)
Equity, Since 28 Feb 23 | FLUOROCHEM4% ₹163 Cr 417,990
↑ 9,104 Bharat Dynamics Ltd Ordinary Shares (Industrials)
Equity, Since 31 Dec 23 | BDL4% ₹162 Cr 1,056,315
↑ 63,547 Amber Enterprises India Ltd Ordinary Shares (Consumer Cyclical)
Equity, Since 31 Mar 24 | AMBER4% ₹148 Cr 240,350
↑ 5,306 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE4% ₹145 Cr 1,055,205 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 29 Feb 24 | MCX4% ₹144 Cr 235,083 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | KALYANKJIL4% ₹139 Cr 2,700,149 Suzlon Energy Ltd (Industrials)
Equity, Since 31 Jan 24 | SUZLON4% ₹139 Cr 24,702,337
↑ 633,524 4. Motilal Oswal Multicap 35 Fund
CAGR/Annualized return of 17.6% since its launch. Ranked 5 in Multi Cap category. Return for 2024 was 45.7% , 2023 was 31% and 2022 was -3% . Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (16 May 25) ₹60.1363 ↑ 0.13 (0.22 %) Net Assets (Cr) ₹12,267 on 31 Mar 25 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 0.94 Sharpe Ratio 0.56 Information Ratio 0.79 Alpha Ratio 11.84 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹14,099 30 Apr 22 ₹14,698 30 Apr 23 ₹14,918 30 Apr 24 ₹22,918 30 Apr 25 ₹26,106 Returns for Motilal Oswal Multicap 35 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 8.5% 3 Month 9.5% 6 Month 2.5% 1 Year 19.1% 3 Year 26.4% 5 Year 24.2% 10 Year 15 Year Since launch 17.6% Historical performance (Yearly) on absolute basis
Year Returns 2024 45.7% 2023 31% 2022 -3% 2021 15.3% 2020 10.3% 2019 7.9% 2018 -7.8% 2017 43.1% 2016 8.5% 2015 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.58 Yr. Niket Shah 1 Jul 22 2.83 Yr. Rakesh Shetty 22 Nov 22 2.44 Yr. Atul Mehra 1 Oct 24 0.58 Yr. Sunil Sawant 1 Jul 24 0.83 Yr. Data below for Motilal Oswal Multicap 35 Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Technology 22.21% Industrials 17.67% Consumer Cyclical 13.37% Financial Services 8.49% Communication Services 5.69% Consumer Defensive 3.15% Health Care 1.77% Asset Allocation
Asset Class Value Cash 28.32% Equity 71.68% Top Securities Holdings / Portfolio
Name Holding Value Quantity Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE10% ₹1,260 Cr 1,725,000
↑ 228,975 Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT9% ₹1,171 Cr 2,200,000
↑ 207,900 Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB9% ₹1,104 Cr 1,999,875
↑ 5,800 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL7% ₹924 Cr 17,885,620
↑ 380,009 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 Jan 25 | 5000936% ₹757 Cr 12,074,170
↑ 416,875 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | 5002516% ₹722 Cr 1,394,889
↓ -5,611 Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services)
Equity, Since 30 Apr 24 | 8901576% ₹707 Cr 4,999,500
↓ -500 Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN5% ₹671 Cr 4,500,000 Varun Beverages Ltd (Consumer Defensive)
Equity, Since 31 Mar 25 | VBL3% ₹392 Cr 7,500,000
↓ -1,332,625 ICICI Bank Ltd (Financial Services)
Equity, Since 28 Feb 21 | ICICIBANK3% ₹357 Cr 2,499,500
↓ -500 5. Invesco India Mid Cap Fund
CAGR/Annualized return of 16.8% since its launch. Ranked 38 in Mid Cap category. Return for 2024 was 43.1% , 2023 was 34.1% and 2022 was 0.5% . Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (16 May 25) ₹166.99 ↑ 0.50 (0.30 %) Net Assets (Cr) ₹5,779 on 31 Mar 25 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.89 Sharpe Ratio 0.56 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹15,625 30 Apr 22 ₹19,175 30 Apr 23 ₹20,440 30 Apr 24 ₹30,748 30 Apr 25 ₹35,711 Returns for Invesco India Mid Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 8.9% 3 Month 14.4% 6 Month 4.4% 1 Year 21.8% 3 Year 29.8% 5 Year 31.3% 10 Year 15 Year Since launch 16.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 43.1% 2023 34.1% 2022 0.5% 2021 43.1% 2020 24.4% 2019 3.8% 2018 -5.3% 2017 44.3% 2016 1.1% 2015 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Aditya Khemani 9 Nov 23 1.47 Yr. Amit Ganatra 1 Sep 23 1.66 Yr. Data below for Invesco India Mid Cap Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Financial Services 24.93% Health Care 19.78% Consumer Cyclical 16.18% Industrials 11.5% Basic Materials 9.42% Technology 9.31% Real Estate 6.89% Communication Services 1.79% Asset Allocation
Asset Class Value Cash 0.2% Equity 99.8% Top Securities Holdings / Portfolio
Name Holding Value Quantity BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE5% ₹278 Cr 506,411
↑ 69,877 L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF4% ₹258 Cr 16,854,973 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH4% ₹246 Cr 2,246,434 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK4% ₹241 Cr 12,506,782 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Apr 21 | 5002514% ₹224 Cr 421,151
↑ 34,656 JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT4% ₹213 Cr 431,234 Dixon Technologies (India) Ltd (Technology)
Equity, Since 28 Feb 22 | DIXON4% ₹205 Cr 155,335 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE3% ₹196 Cr 1,657,183
↑ 95,829 Max Financial Services Ltd (Financial Services)
Equity, Since 30 Nov 23 | 5002713% ₹193 Cr 1,684,103 Coforge Ltd (Technology)
Equity, Since 31 Mar 22 | COFORGE3% ₹190 Cr 234,918 6. UTI Healthcare Fund
CAGR/Annualized return of 14.9% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (16 May 25) ₹272.199 ↓ -0.51 (-0.19 %) Net Assets (Cr) ₹1,042 on 31 Mar 25 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 0.66 Information Ratio -0.23 Alpha Ratio 1.04 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹15,214 30 Apr 22 ₹15,571 30 Apr 23 ₹15,015 30 Apr 24 ₹22,423 30 Apr 25 ₹27,036 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 2.7% 3 Month 6.2% 6 Month -2.2% 1 Year 21.5% 3 Year 23.6% 5 Year 22.5% 10 Year 15 Year Since launch 14.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 3 Yr. Data below for UTI Healthcare Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Health Care 97.95% Basic Materials 0.97% Asset Allocation
Asset Class Value Cash 1.08% Equity 98.92% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA12% ₹123 Cr 672,889
↓ -27,111 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000876% ₹62 Cr 400,000
↓ -20,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹47 Cr 396,000 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323315% ₹47 Cr 172,829
↓ -2,056 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL4% ₹41 Cr 79,763
↑ 5,763 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹39 Cr 56,271 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹38 Cr 275,250 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹34 Cr 56,000 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 May 21 | ALKEM3% ₹33 Cr 63,840 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹32 Cr 465,000 7. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 15.5% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (15 May 25) ₹418.188 ↑ 2.40 (0.58 %) Net Assets (Cr) ₹3,611 on 31 Mar 25 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 0.77 Information Ratio 0.67 Alpha Ratio 2.51 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹15,282 30 Apr 22 ₹15,865 30 Apr 23 ₹16,168 30 Apr 24 ₹24,854 30 Apr 25 ₹30,132 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 2.2% 3 Month 5.7% 6 Month 1.2% 1 Year 20.7% 3 Year 27.4% 5 Year 24.9% 10 Year 15 Year Since launch 15.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.92 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Health Care 91.24% Basic Materials 6.15% Asset Allocation
Asset Class Value Cash 2.6% Equity 97.4% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA14% ₹513 Cr 2,800,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB7% ₹243 Cr 400,000
↑ 25,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹231 Cr 2,100,000
↓ -100,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000875% ₹186 Cr 1,200,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LO3A5% ₹182 Cr 300,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002575% ₹176 Cr 840,000 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED4% ₹139 Cr 540,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹138 Cr 560,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433084% ₹134 Cr 2,034,372
↓ -65,628 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL3% ₹117 Cr 800,000 8. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 12.3% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (16 May 25) ₹29.5738 ↓ -0.03 (-0.12 %) Net Assets (Cr) ₹1,184 on 31 Mar 25 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 0.42 Information Ratio 0.57 Alpha Ratio 2.09 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹14,766 30 Apr 22 ₹15,521 30 Apr 23 ₹15,212 30 Apr 24 ₹23,213 30 Apr 25 ₹27,062 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 3.3% 3 Month 6.2% 6 Month 0.6% 1 Year 17.4% 3 Year 23.7% 5 Year 22.5% 10 Year 15 Year Since launch 12.3% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 4.15 Yr. Rajat Srivastava 16 Sep 24 0.62 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Health Care 91.11% Basic Materials 2.29% Asset Allocation
Asset Class Value Cash 6.59% Equity 93.41% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA13% ₹157 Cr 854,300
↑ 50,000 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000876% ₹76 Cr 490,000 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA6% ₹76 Cr 615,100
↓ -125,900 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP6% ₹71 Cr 101,255 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹64 Cr 104,965 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002575% ₹64 Cr 303,240 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328435% ₹59 Cr 855,100 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | ASTERDM4% ₹48 Cr 956,991 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM3% ₹38 Cr 75,249 HealthCare Global Enterprises Ltd (Healthcare)
Equity, Since 31 Dec 18 | HCG3% ₹37 Cr 666,121 9. IDBI Small Cap Fund
CAGR/Annualized return of 14.5% since its launch. Return for 2024 was 40% , 2023 was 33.4% and 2022 was 2.4% . IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (16 May 25) ₹29.2733 ↑ 0.19 (0.64 %) Net Assets (Cr) ₹494 on 31 Mar 25 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio 0.29 Information Ratio -0.19 Alpha Ratio 5.7 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹18,100 30 Apr 22 ₹24,313 30 Apr 23 ₹25,270 30 Apr 24 ₹37,716 30 Apr 25 ₹38,352 Returns for IDBI Small Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 2.8% 3 Month 7% 6 Month -7.4% 1 Year 6.3% 3 Year 22.7% 5 Year 33.4% 10 Year 15 Year Since launch 14.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 40% 2023 33.4% 2022 2.4% 2021 64.7% 2020 19% 2019 -4.4% 2018 -15% 2017 2016 2015 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Nikhil Rungta 1 Jul 24 0.83 Yr. Mahesh Bendre 1 Jul 24 0.83 Yr. Data below for IDBI Small Cap Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 34.47% Consumer Cyclical 18.99% Basic Materials 9.6% Consumer Defensive 8.03% Utility 6.81% Financial Services 5.3% Health Care 4.9% Technology 4.1% Communication Services 3.36% Real Estate 0.41% Energy 0.01% Asset Allocation
Asset Class Value Cash 4% Equity 96% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sanathan Textiles Ltd (Consumer Cyclical)
Equity, Since 31 Dec 24 | SANATHAN3% ₹17 Cr 401,251 JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 5346003% ₹16 Cr 2,506,932
↑ 480,066 Housing & Urban Development Corp Ltd (Financial Services)
Equity, Since 31 Oct 24 | HUDCO3% ₹16 Cr 711,662
↓ -40,456 Manorama Industries Ltd (Consumer Defensive)
Equity, Since 31 Dec 24 | 5419743% ₹15 Cr 115,327
↑ 8,520 TD Power Systems Ltd (Industrials)
Equity, Since 31 Aug 23 | TDPOWERSYS3% ₹14 Cr 327,391
↑ 11,229 Concord Enviro Systems Ltd (Utilities)
Equity, Since 31 Dec 24 | CEWATER3% ₹14 Cr 270,441 Hindustan Foods Ltd (Industrials)
Equity, Since 31 Jul 24 | 5191262% ₹12 Cr 220,054
↑ 74,304 International Gemmological Institute (India) Ltd (Basic Materials)
Equity, Since 31 Dec 24 | IGIL2% ₹12 Cr 337,832 Praveg Ltd Ordinary Shares (Communication Services)
Equity, Since 31 Dec 24 | 5316372% ₹12 Cr 212,056
↑ 16,354 Navkar Corp Ltd (Industrials)
Equity, Since 31 Jul 24 | NAVKARCORP2% ₹11 Cr 1,084,277 10. L&T Midcap Fund
CAGR/Annualized return of 19% since its launch. Ranked 5 in Mid Cap category. Return for 2024 was 39.7% , 2023 was 40% and 2022 was 1.1% . L&T Midcap Fund
Growth Launch Date 9 Aug 04 NAV (16 May 25) ₹370.562 ↑ 2.35 (0.64 %) Net Assets (Cr) ₹10,362 on 31 Mar 25 Category Equity - Mid Cap AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk High Expense Ratio 1.77 Sharpe Ratio 0.15 Information Ratio -0.28 Alpha Ratio 0.31 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 30 Apr 20 ₹10,000 30 Apr 21 ₹15,852 30 Apr 22 ₹18,154 30 Apr 23 ₹18,640 30 Apr 24 ₹29,994 30 Apr 25 ₹31,358 Returns for L&T Midcap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 16 May 25 Duration Returns 1 Month 9.5% 3 Month 14% 6 Month -1.6% 1 Year 9.7% 3 Year 26.2% 5 Year 27.9% 10 Year 15 Year Since launch 19% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.7% 2023 40% 2022 1.1% 2021 30.4% 2020 19% 2019 -0.2% 2018 -12% 2017 52.3% 2016 9.8% 2015 10.8% Fund Manager information for L&T Midcap Fund
Name Since Tenure Venugopal Manghat 1 Oct 23 1.58 Yr. Cheenu Gupta 26 Nov 22 2.43 Yr. Sonal Gupta 1 Oct 23 1.58 Yr. Data below for L&T Midcap Fund as on 31 Mar 25
Equity Sector Allocation
Sector Value Industrials 24.25% Consumer Cyclical 18.67% Financial Services 16.23% Technology 14.96% Health Care 13.26% Consumer Defensive 3.76% Utility 2.42% Basic Materials 1.92% Communication Services 1.67% Real Estate 1.56% Asset Allocation
Asset Class Value Cash 1.3% Equity 98.7% Top Securities Holdings / Portfolio
Name Holding Value Quantity Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Sep 21 | MAXHEALTH5% ₹478 Cr 4,355,000
↑ 246,080 Persistent Systems Ltd (Technology)
Equity, Since 30 Nov 22 | PERSISTENT4% ₹456 Cr 827,298 BSE Ltd (Financial Services)
Equity, Since 30 Apr 24 | BSE4% ₹439 Cr 800,300 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Apr 24 | DIXON4% ₹402 Cr 304,800 Indian Hotels Co Ltd (Consumer Cyclical)
Equity, Since 30 Apr 18 | 5008504% ₹377 Cr 4,782,177 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Jun 19 | 5002514% ₹363 Cr 681,700 The Federal Bank Ltd (Financial Services)
Equity, Since 31 Jan 22 | FEDERALBNK3% ₹362 Cr 18,801,000 Coforge Ltd (Technology)
Equity, Since 31 Jul 24 | COFORGE3% ₹357 Cr 439,900 Lupin Ltd (Healthcare)
Equity, Since 31 Dec 22 | 5002573% ₹356 Cr 1,757,400
↑ 125,300 Eternal Ltd (Consumer Cyclical)
Equity, Since 31 Mar 24 | 5433203% ₹355 Cr 17,596,500
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved